Published 2005 | ISBN 1 84463 025 0 | Archived
Over the last year we have built on the solid foundations of a programme that has had continuing success. It is widely recognised that cervical screening is currently the best defence against cervical cancer and can prevent around 75 per cent of cancer cases in women who attend regularly.
We have made significant progress since the screening programme began in 1988 and millions of women have taken up the offer of screening. Last year over 3.2 million women in the target age range were screened.
In this annual review we report on the way screening services are being adapted to accommodate the introduction of liquid based cytology (LBC), a new way of preparing cervical samples for examination in the laboratory. We are on track for completing the roll-out of LBC by 2008. Already, we are reaping the rewards that this new technology brings and my thanks go to staff who work in the programme for their continued support and efforts in making roll-out possible.
- NHSCSP home page
- Programme publications
- About cervical screening
- Human Papilloma Virus (HPV)
- Research in cervical screening
- More information about the
screening programme- Information about cervical cancer
- Diethylstilbestrol (DES) exposed women
- Liquid Based Cytology (LBC)
- LBC implementation guidance
- Who does what in the programme
- Quality Assurance
- Use of patient information
- Cervical cytology training centres
- Human Papilloma virus (HPV)
- HPV triage and test of cure protocol
- HMR101 Request/Report Form
- 14 day turnaround time
- Frequently asked questions
- Programme statistics
- Programme news index
- Useful links